ETOMIDATE

ETOMIDATE was reported 2262 times

ETOMIDATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD BROMIDE INCREASED 5 0.2381
1 INTUBATION COMPLICATION 7 0.1373
2 CATECHOLAMINE CRISIS 5 0.1351
3 FIBRINOLYSIS INCREASED 5 0.1250
4 BURKHOLDERIA TEST POSITIVE 12 0.0968
5 BISPECTRAL INDEX DECREASED 1 0.0833
6 PHAEOCHROMOCYTOMA CRISIS 17 0.0802
7 CHEST WALL RIGIDITY 4 0.0625
8 MENINGITIS CANDIDA 4 0.0571
9 HYPERPLASIA ADRENAL 3 0.0476
10 HAEMODYNAMIC TEST ABNORMAL 3 0.0448
11 ANAESTHETIC COMPLICATION CARDIAC 3 0.0435
12 ANAESTHETIC COMPLICATION NEUROLOGICAL 39 0.0430
13 OXIDATIVE STRESS 4 0.0426
14 MECHANICAL VENTILATION COMPLICATION 5 0.0336
15 WRONG PRODUCT STORED 9 0.0317
16 BASILAR ARTERY ANEURYSM 1 0.0303
17 HYPERTHERMIA MALIGNANT 44 0.0296
18 AIRWAY PEAK PRESSURE INCREASED 4 0.0263
19 BENCE JONES PROTEINURIA 1 0.0250
20 NEUROMUSCULAR BLOCK PROLONGED 9 0.0244
21 ACQUIRED METHAEMOGLOBINAEMIA 1 0.0227
22 GASTROINTESTINAL ISCHAEMIA 6 0.0217
23 INJECTION SITE PHLEBITIS 5 0.0214
24 PULMONARY HYPERTENSIVE CRISIS 5 0.0185
25 CARBOXYHAEMOGLOBIN INCREASED 1 0.0167
26 BRONCHOALVEOLAR LAVAGE 1 0.0164
27 CENTRAL VENOUS PRESSURE INCREASED 2 0.0164
28 ADRENAL ATROPHY 1 0.0161
29 UTERINE ATONY 4 0.0153
30 AIRWAY COMPLICATION OF ANAESTHESIA 4 0.0152
31 CEREBROVASCULAR SPASM 2 0.0152
32 STARVATION KETOACIDOSIS 3 0.0149
33 DISORDER OF ORBIT 2 0.0139
34 TRACHEAL INJURY 2 0.0136
35 SPINAL CORD ISCHAEMIA 2 0.0132
36 POSTICTAL PARALYSIS 3 0.0124
37 THYROTOXIC CRISIS 14 0.0123
38 CEREBRAL CONGESTION 2 0.0119
39 PNEUMOPERICARDIUM 2 0.0116
40 ANAESTHETIC COMPLICATION PULMONARY 1 0.0112
41 INFUSION SITE THROMBOSIS 3 0.0112
42 POSTOPERATIVE FEVER 3 0.0107
43 BRONCHIAL OEDEMA 1 0.0106
44 BILE OUTPUT INCREASED 1 0.0105
45 BLOOD CORTICOTROPHIN ABNORMAL 1 0.0104
46 AUTOIMMUNE ENCEPHALOPATHY 1 0.0099
47 DIABETES INSIPIDUS 23 0.0095
48 METHAEMOGLOBINAEMIA 22 0.0095
49 ADRENAL SUPPRESSION 8 0.0095
50 OROANTRAL FISTULA 2 0.0092
51 PLACENTA ACCRETA 2 0.0092
52 PSEUDOMONAL SEPSIS 16 0.0091
53 SEVERE ACUTE RESPIRATORY SYNDROME 2 0.0091
54 SCINTILLATING SCOTOMA 2 0.0091
55 THERAPEUTIC PRODUCT EFFECT PROLONGED 4 0.0088
56 CARDIAC DEATH 10 0.0083
57 WEANING FAILURE 3 0.0082
58 GINGIVAL EROSION 2 0.0078
59 DENTURE WEARER 2 0.0077
60 CARDIAC ARREST NEONATAL 1 0.0072
61 ADDISON'S DISEASE 1 0.0069
62 HYPEROSMOLAR STATE 2 0.0069
63 OPERATIVE HAEMORRHAGE 3 0.0067
64 PRODUCT PACKAGING CONFUSION 16 0.0066
65 MYOCARDIAL RUPTURE 2 0.0066
66 BLOOD CREATININE 1 0.0065
67 PRODUCT APPEARANCE CONFUSION 6 0.0065
68 CORTISOL INCREASED 4 0.0064
69 DELAYED RECOVERY FROM ANAESTHESIA 6 0.0063
70 FOETAL CARDIAC DISORDER 2 0.0063
71 MULTI-ORGAN FAILURE 107 0.0062
72 MATERNAL EXPOSURE DURING DELIVERY 6 0.0061
73 BRADYCARDIA FOETAL 5 0.0060
74 PO2 INCREASED 3 0.0059
75 OXYGEN SATURATION INCREASED 2 0.0059
76 ACUTE CARDIAC EVENT 1 0.0058
77 ANAEMIA OF PREGNANCY 1 0.0058
78 ENDOCRINE OPHTHALMOPATHY 5 0.0058
79 FEAR 154 0.0057
80 PROPOFOL INFUSION SYNDROME 4 0.0057
81 HYPERMETABOLISM 3 0.0057
82 ADRENOCORTICAL INSUFFICIENCY ACUTE 11 0.0056
83 ECLAMPSIA 2 0.0054
84 BIFASCICULAR BLOCK 1 0.0053
85 ALVEOLAR LUNG DISEASE 1 0.0053
86 ENDOTRACHEAL INTUBATION COMPLICATION 3 0.0051
87 ASTROCYTOMA 2 0.0051
88 KOUNIS SYNDROME 11 0.0048
89 BRONCHOALVEOLAR LAVAGE ABNORMAL 1 0.0048
90 BONE SCAN ABNORMAL 2 0.0047
91 PROCEDURAL HYPOTENSION 4 0.0047
92 CYANOSIS NEONATAL 3 0.0047
93 HAEMORRHAGIC DISORDER 5 0.0046
94 RENAL INJURY 134 0.0045
95 ACID BASE BALANCE ABNORMAL 1 0.0045
96 ANAESTHETIC COMPLICATION 12 0.0045
97 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 2 0.0044
98 CARCINOID CRISIS 1 0.0044
99 ISCHAEMIC HEPATITIS 6 0.0044
100 APPENDICITIS PERFORATED 11 0.0043
101 PULSELESS ELECTRICAL ACTIVITY 18 0.0043
102 VASOPLEGIA SYNDROME 7 0.0043
103 ANHEDONIA 112 0.0043
104 MASTOCYTOSIS 2 0.0042
105 SUBCUTANEOUS EMPHYSEMA 4 0.0041
106 HYPERAEMIA 8 0.0041
107 APGAR SCORE LOW 5 0.0039
108 BRUGADA SYNDROME 4 0.0039
109 TONIC CLONIC MOVEMENTS 5 0.0038
110 GRIMACING 3 0.0038
111 ELECTROMECHANICAL DISSOCIATION 3 0.0038
112 MYOGLOBINURIA 2 0.0038
113 CEREBRAL ARTERY OCCLUSION 4 0.0037
114 BLOOD GASES ABNORMAL 2 0.0037
115 POSTPARTUM HAEMORRHAGE 5 0.0037
116 HEART INJURY 9 0.0036
117 LUNG INFECTION PSEUDOMONAL 2 0.0036
118 FEAR OF DEATH 8 0.0036
119 MYOCARDIAL INJURY 4 0.0036
120 VENTRICULAR FIBRILLATION 39 0.0035
121 BURKHOLDERIA CEPACIA COMPLEX INFECTION 1 0.0035
122 BLOOD CORTICOTROPHIN INCREASED 1 0.0035
123 ADNEXA UTERI MASS 1 0.0035
124 VICTIM OF HOMICIDE 2 0.0034
125 CAPILLARY LEAK SYNDROME 7 0.0034
126 PALATAL DISORDER 2 0.0033
127 RESPIRATORY ACIDOSIS 13 0.0033
128 HYPERAESTHESIA TEETH 4 0.0032
129 BLOOD CORTISOL DECREASED 2 0.0031
130 HYPOGLYCAEMIA NEONATAL 5 0.0031
131 AUTONOMIC NERVOUS SYSTEM IMBALANCE 9 0.0031
132 PROCEDURAL VOMITING 2 0.0031
133 ANAPHYLACTIC SHOCK 78 0.0030
134 BLOOD LACTATE DEHYDROGENASE DECREASED 1 0.0030
135 ACUTE STRESS DISORDER 1 0.0030
136 ARRHYTHMIC STORM 1 0.0030
137 HYPERCAPNIA 9 0.0030
138 BENIGN NEOPLASM OF SKIN 1 0.0030
139 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 2 0.0029
140 ANION GAP DECREASED 1 0.0029
141 PULMONARY VALVE INCOMPETENCE 4 0.0027
142 RIGHT VENTRICULAR DYSFUNCTION 3 0.0027
143 FIBROCYSTIC BREAST DISEASE 2 0.0027
144 OSMOTIC DEMYELINATION SYNDROME 2 0.0027
145 ANISOCORIA 1 0.0026
146 INJURY 186 0.0026
147 ELECTROCARDIOGRAM PR PROLONGATION 2 0.0026
148 PO2 DECREASED 3 0.0026
149 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 4 0.0026
150 PULMONARY ARTERY THROMBOSIS 2 0.0026
151 APNOEA 20 0.0026
152 SEROTONIN SYNDROME 49 0.0025
153 TORSADE DE POINTES 20 0.0025
154 LABORATORY TEST INTERFERENCE 2 0.0025
155 PNEUMONIA STAPHYLOCOCCAL 5 0.0025
156 PRODUCT CONTAMINATION MICROBIAL 3 0.0025
157 HAEMOPERITONEUM 2 0.0025
158 BRAIN COMPRESSION 1 0.0025
159 HAEMODYNAMIC INSTABILITY 19 0.0025
160 PERFORATION 2 0.0025
161 ORGAN FAILURE 10 0.0025
162 ENTEROCOCCAL SEPSIS 2 0.0025
163 SPUTUM CULTURE POSITIVE 2 0.0025
164 RESPIRATORY ALKALOSIS 4 0.0025
165 INFANTILE APNOEA 2 0.0025
166 ARTERIAL THROMBOSIS LIMB 1 0.0024
167 COLLAPSE OF LUNG 2 0.0024
168 MICROCYTIC ANAEMIA 5 0.0024
169 MYOCLONUS 28 0.0023
170 BLOOD PH DECREASED 4 0.0023
171 BELLIGERENCE 1 0.0023
172 PUPIL FIXED 4 0.0023
173 ALCOHOL WITHDRAWAL SYNDROME 2 0.0023
174 VASCULAR DEMENTIA 2 0.0023
175 INTRACARDIAC THROMBUS 7 0.0023
176 CARDIAC OUTPUT DECREASED 2 0.0023
177 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
178 UNEVALUABLE EVENT 168 0.0022
179 RIGHT VENTRICULAR HYPERTROPHY 2 0.0022
180 PNEUMOMEDIASTINUM 4 0.0022
181 PRURIGO 2 0.0022
182 HYPOVENTILATION 7 0.0021
183 BUNDLE BRANCH BLOCK 2 0.0021
184 HYPERPYREXIA 9 0.0021
185 AIR EMBOLISM 1 0.0021
186 BRAIN STEM HAEMORRHAGE 2 0.0021
187 PCO2 DECREASED 2 0.0021
188 MUSCLE RIGIDITY 24 0.0020
189 PRODUCT MEASURED POTENCY ISSUE 2 0.0020
190 SECONDARY ADRENOCORTICAL INSUFFICIENCY 3 0.0020
191 HYPERTHERMIA 15 0.0020
192 RUBBER SENSITIVITY 3 0.0020
193 SEDATION COMPLICATION 5 0.0020
194 PERIPHERAL ISCHAEMIA 8 0.0020
195 BRAIN STEM INFARCTION 2 0.0020
196 POSTICTAL STATE 2 0.0019
197 LIVEDO RETICULARIS 4 0.0019
198 RESPIRATORY RATE DECREASED 6 0.0019
199 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
200 VENTRICULAR TACHYCARDIA 31 0.0019
201 RESPIRATORY DEPRESSION 23 0.0019
202 RIGHT VENTRICULAR FAILURE 13 0.0019
203 CARDIOVASCULAR INSUFFICIENCY 3 0.0018
204 CLONUS 5 0.0018
205 SHOCK 42 0.0018
206 INTERCEPTED PRODUCT DISPENSING ERROR 3 0.0018
207 BLOOD MAGNESIUM ABNORMAL 1 0.0018
208 RENAL FAILURE 239 0.0018
209 BRAIN SCAN ABNORMAL 1 0.0018
210 CARDIAC ARREST 148 0.0018
211 ENDOTRACHEAL INTUBATION 5 0.0018
212 TONSILLAR DISORDER 2 0.0018
213 APNOEIC ATTACK 1 0.0018
214 SEIZURE LIKE PHENOMENA 3 0.0018
215 VASCULAR PSEUDOANEURYSM 3 0.0017
216 HYPERREFLEXIA 6 0.0017
217 AORTIC CALCIFICATION 1 0.0017
218 STRESS CARDIOMYOPATHY 10 0.0017
219 PROCALCITONIN INCREASED 2 0.0017
220 NYSTAGMUS 9 0.0017
221 LABILE BLOOD PRESSURE 2 0.0017
222 ADRENAL INSUFFICIENCY 20 0.0016
223 CEREBRAL ARTERY EMBOLISM 2 0.0016
224 HEPARIN-INDUCED THROMBOCYTOPENIA 8 0.0016
225 PALATAL OEDEMA 2 0.0016
226 ACCIDENTAL DEATH 3 0.0016
227 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 2 0.0016
228 CARDIOGENIC SHOCK 23 0.0016
229 DERMATITIS EXFOLIATIVE 8 0.0016
230 BRONCHIAL SECRETION RETENTION 2 0.0016
231 PROCEDURAL COMPLICATION 12 0.0016
232 TRISMUS 8 0.0015
233 BRADYCARDIA 82 0.0015
234 PRODUCT LABEL CONFUSION 9 0.0015
235 HEPATITIS TOXIC 4 0.0015
236 MULTI-ORGAN DISORDER 3 0.0015
237 RENAL IMPAIRMENT 127 0.0015
238 GENERALISED TONIC-CLONIC SEIZURE 25 0.0015
239 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 5 0.0015
240 BONE DEFORMITY 1 0.0015
241 RHABDOMYOLYSIS 62 0.0015
242 RENAL FAILURE ACUTE 63 0.0015
243 BRUXISM 8 0.0015
244 ABSCESS NECK 1 0.0015
245 POISONING DELIBERATE 14 0.0015
246 EFFUSION 2 0.0015
247 EUGLYCAEMIC DIABETIC KETOACIDOSIS 6 0.0015
248 RHONCHI 2 0.0014
249 PERIODONTAL DISEASE 2 0.0014
250 MAST CELL ACTIVATION SYNDROME 2 0.0014
251 BRONCHIAL OBSTRUCTION 2 0.0014
252 MUSCLE CONTRACTIONS INVOLUNTARY 5 0.0014
253 BRONCHOSPASM 20 0.0014
254 HYPERTONIA 8 0.0014
255 EXOPHTHALMOS 3 0.0014
256 JAW FRACTURE 3 0.0014
257 NODAL RHYTHM 2 0.0014
258 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 3 0.0014
259 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 7 0.0014
260 CARDIAC FAILURE ACUTE 9 0.0013
261 BRAIN HERNIATION 4 0.0013
262 BRAIN STEM SYNDROME 1 0.0013
263 STATUS EPILEPTICUS 15 0.0013
264 COMPUTERISED TOMOGRAM ABNORMAL 3 0.0013
265 MYOCLONIC EPILEPSY 2 0.0013
266 MULTIPLE ORGAN DYSFUNCTION SYNDROME 37 0.0013
267 BLOOD PRESSURE IMMEASURABLE 2 0.0013
268 POST PROCEDURAL COMPLICATION 25 0.0013
269 NEPHROGENIC ANAEMIA 6 0.0013
270 EJECTION FRACTION DECREASED 20 0.0013
271 METABOLIC ACIDOSIS 41 0.0013
272 HYPOTONIA NEONATAL 2 0.0013
273 FUNGAEMIA 2 0.0013
274 PULSE ABSENT 6 0.0013
275 ACUTE RESPIRATORY FAILURE 24 0.0012
276 RENAL TUBULAR NECROSIS 12 0.0012
277 RESUSCITATION 2 0.0012
278 VENA CAVA THROMBOSIS 2 0.0012
279 TACHYARRHYTHMIA 3 0.0012
280 GASTRIC DILATATION 2 0.0012
281 MYOCARDIAL NECROSIS MARKER INCREASED 2 0.0012
282 EMOTIONAL DISTRESS 144 0.0012
283 HEPATORENAL SYNDROME 2 0.0012
284 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
285 ADENOMA BENIGN 1 0.0012
286 BLOOD CHLORIDE INCREASED 2 0.0012
287 RECALLED PRODUCT 2 0.0012
288 SPLENIC INFARCTION 2 0.0011
289 CATATONIA 6 0.0011
290 THROMBOPHLEBITIS 4 0.0011
291 ACUTE CHEST SYNDROME 1 0.0011
292 ABDOMINAL SEPSIS 1 0.0011
293 LUNG TRANSPLANT 4 0.0011
294 FIBRIN D DIMER INCREASED 4 0.0011
295 SHOCK HAEMORRHAGIC 9 0.0011
296 NEUROLEPTIC MALIGNANT SYNDROME 13 0.0011
297 ESSENTIAL HYPERTENSION 2 0.0011
298 IMMUNE THROMBOCYTOPENIA 5 0.0011
299 CONDUCTION DISORDER 2 0.0011
300 PNEUMONIA KLEBSIELLA 2 0.0011
301 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
302 HYPOXIA 38 0.0011
303 ADENOCARCINOMA GASTRIC 1 0.0011
304 PROCTITIS 3 0.0011
305 BONE CYST 1 0.0011
306 BLOOD BICARBONATE DECREASED 2 0.0011
307 MECHANICAL VENTILATION 2 0.0011
308 COMA 50 0.0010
309 ACIDOSIS 8 0.0010
310 METABOLIC DISORDER 6 0.0010
311 GASTROINTESTINAL NECROSIS 3 0.0010
312 NASAL SEPTUM DEVIATION 2 0.0010
313 BACTERAEMIA 12 0.0010
314 CARDIAC ANEURYSM 1 0.0010
315 ACQUIRED HAEMOPHILIA 1 0.0010
316 DISSEMINATED INTRAVASCULAR COAGULATION 14 0.0010
317 ATRIOVENTRICULAR BLOCK SECOND DEGREE 3 0.0010
318 AUTONOMIC NEUROPATHY 1 0.0010
319 OSTEOLYSIS 2 0.0010
320 GRAND MAL CONVULSION 9 0.0010
321 LARYNGEAL OEDEMA 6 0.0010
322 ANAPHYLACTOID REACTION 4 0.0010
323 POLYCYTHAEMIA 2 0.0010
324 ATRIAL THROMBOSIS 2 0.0010
325 ABSCESS JAW 1 0.0010
326 TACHYPNOEA 13 0.0010
327 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
328 ELECTROCARDIOGRAM QT PROLONGED 34 0.0009
329 BUNDLE BRANCH BLOCK LEFT 4 0.0009
330 SCREAMING 6 0.0009
331 PURULENT DISCHARGE 4 0.0009
332 KETOACIDOSIS 7 0.0009
333 RESPIRATORY FAILURE 68 0.0009
334 OESOPHAGEAL VARICES HAEMORRHAGE 2 0.0009
335 BACTERIAL SEPSIS 3 0.0009
336 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
337 SEPTIC SHOCK 40 0.0009
338 HYDROCEPHALUS 5 0.0009
339 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
340 PERICARDIAL HAEMORRHAGE 2 0.0009
341 DEAFNESS NEUROSENSORY 3 0.0009
342 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
343 ACUTE RESPIRATORY DISTRESS SYNDROME 16 0.0009
344 ATRIOVENTRICULAR BLOCK COMPLETE 6 0.0009
345 CHRONIC GASTRITIS 2 0.0009
346 HYPERKALAEMIA 31 0.0009
347 DISTRIBUTIVE SHOCK 2 0.0009
348 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
349 MYOCARDIAL ISCHAEMIA 10 0.0009
350 BLOOD FIBRINOGEN DECREASED 1 0.0009
351 BRONCHOPNEUMONIA 3 0.0009
352 ARTERIAL HAEMORRHAGE 1 0.0009
353 BRAIN OEDEMA 11 0.0009
354 AORTIC THROMBOSIS 1 0.0009
355 ACUTE PRERENAL FAILURE 1 0.0009
356 POST PROCEDURAL HAEMORRHAGE 10 0.0009
357 NECROTISING FASCIITIS 3 0.0009
358 SINUS TACHYCARDIA 12 0.0008
359 PRODUCT CONTAMINATION 3 0.0008
360 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6 0.0008
361 LONG QT SYNDROME 2 0.0008
362 RESPIRATORY DISTRESS 23 0.0008
363 BRONCHIAL HYPERREACTIVITY 1 0.0008
364 ATELECTASIS 8 0.0008
365 RASH VESICULAR 4 0.0008
366 CIRCULATORY COLLAPSE 14 0.0008
367 RETROPERITONEAL HAEMORRHAGE 2 0.0008
368 OLIGURIA 5 0.0008
369 INTRAVENTRICULAR HAEMORRHAGE 2 0.0008
370 PULMONARY OEDEMA 36 0.0008
371 HYPOTENSION 159 0.0008
372 RETINAL ARTERY OCCLUSION 2 0.0008
373 TONGUE OEDEMA 3 0.0008
374 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
375 INTERCEPTED PRODUCT ADMINISTRATION ERROR 6 0.0008
376 PHLEBITIS 4 0.0008
377 RENAL FAILURE CHRONIC 6 0.0008
378 ENCEPHALOPATHY 19 0.0008
379 VENTRICULAR DYSFUNCTION 2 0.0008
380 DRUG ABUSE 64 0.0008
381 POSTMENOPAUSAL HAEMORRHAGE 2 0.0008
382 COMPARTMENT SYNDROME 2 0.0008
383 ANAEMIA POSTOPERATIVE 1 0.0008
384 CARDIO-RESPIRATORY ARREST 32 0.0008
385 BLOOD LACTIC ACID INCREASED 4 0.0008
386 TRICUSPID VALVE INCOMPETENCE 6 0.0008
387 AREFLEXIA 2 0.0007
388 CANDIDIASIS 3 0.0007
389 CARBON DIOXIDE INCREASED 1 0.0007
390 GOITRE 3 0.0007
391 SUBDURAL HAEMORRHAGE 2 0.0007
392 ACCIDENTAL POISONING 1 0.0007
393 INTESTINAL ISCHAEMIA 4 0.0007
394 BILIARY TRACT DISORDER 1 0.0007
395 RASH MORBILLIFORM 2 0.0007
396 CONGESTIVE CARDIOMYOPATHY 3 0.0007
397 TRANSAMINASES INCREASED 16 0.0007
398 DISABILITY 14 0.0007
399 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
400 AUDITORY DISORDER 1 0.0007
401 PNEUMOCYSTIS JIROVECII PNEUMONIA 7 0.0007
402 ANAPHYLACTIC REACTION 38 0.0007
403 HYPOVOLAEMIA 4 0.0007
404 PULMONARY CONGESTION 9 0.0007
405 LUNG INFILTRATION 6 0.0007
406 GINGIVAL SWELLING 3 0.0007
407 CHOLESTASIS 13 0.0007
408 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 4 0.0007
409 BLOOD CULTURE POSITIVE 2 0.0007
410 METABOLIC ENCEPHALOPATHY 2 0.0007
411 NORMOCHROMIC NORMOCYTIC ANAEMIA 2 0.0007
412 COAGULOPATHY 11 0.0007
413 UNRESPONSIVE TO STIMULI 17 0.0007
414 CARDIOMEGALY 8 0.0006
415 DIASTOLIC DYSFUNCTION 2 0.0006
416 BRONCHIAL DISORDER 1 0.0006
417 ANXIETY 181 0.0006
418 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
419 DRUG SCREEN POSITIVE 5 0.0006
420 TACHYCARDIA 56 0.0006
421 ANTICHOLINERGIC SYNDROME 1 0.0006
422 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
423 VENTRICULAR HYPOKINESIA 2 0.0006
424 ENTEROCOCCAL INFECTION 3 0.0006
425 SINUS BRADYCARDIA 6 0.0006
426 AORTIC VALVE DISEASE 1 0.0006
427 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
428 ACUTE LEUKAEMIA 1 0.0006
429 DECUBITUS ULCER 5 0.0006
430 THERAPY CHANGE 6 0.0006
431 BRADYARRHYTHMIA 1 0.0006
432 HYPERNATRAEMIA 3 0.0006
433 HEPATIC ENZYME ABNORMAL 3 0.0006
434 OLIGOHYDRAMNIOS 2 0.0006
435 ANXIETY DISORDER 2 0.0006
436 HAEMODIALYSIS 5 0.0006
437 COVID-19 PNEUMONIA 7 0.0006
438 HEPATIC CYST 2 0.0006
439 AGITATION 43 0.0006
440 ENDOCARDITIS 3 0.0006
441 CEREBRAL ISCHAEMIA 3 0.0006
442 PERIPHERAL VASCULAR DISORDER 3 0.0006
443 LYMPHOMA 9 0.0006
444 PYELONEPHRITIS 5 0.0006
445 HYPOPNOEA 2 0.0006
446 MENTAL STATUS CHANGES 16 0.0006
447 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
448 DRUG INTERACTION 91 0.0006
449 URINE OUTPUT DECREASED 5 0.0006
450 TYPE I HYPERSENSITIVITY 2 0.0006
451 PREMATURE DELIVERY 9 0.0006
452 RESPIRATORY RATE INCREASED 5 0.0006
453 INTERCEPTED PRODUCT STORAGE ERROR 2 0.0006
454 COMPRESSION FRACTURE 3 0.0006
455 PARALYSIS 8 0.0006
456 DRUG EXPOSURE DURING PREGNANCY 19 0.0006
457 BONE LESION 2 0.0006
458 HYPERTHYROIDISM 8 0.0006
459 LEUKOCYTOSIS 10 0.0006
460 BLOOD PHOSPHORUS DECREASED 2 0.0005
461 PNEUMONIA BACTERIAL 5 0.0005
462 HEART RATE DECREASED 19 0.0005
463 ACUTE PULMONARY OEDEMA 3 0.0005
464 ATRIAL FIBRILLATION 52 0.0005
465 OXYGEN SATURATION DECREASED 30 0.0005
466 HEPATIC NECROSIS 2 0.0005
467 CARDIAC VALVE DISEASE 3 0.0005
468 ARTERIAL DISORDER 1 0.0005
469 MATERNAL DRUGS AFFECTING FOETUS 4 0.0005
470 ADRENAL DISORDER 1 0.0005
471 HYPERVENTILATION 3 0.0005
472 ARTERIAL THROMBOSIS 1 0.0005
473 RALES 3 0.0005
474 DYSTONIA 10 0.0005
475 CAESAREAN SECTION 6 0.0005
476 ATROPHY 1 0.0005
477 SEPSIS 57 0.0005
478 CYANOSIS 8 0.0005
479 LOW BIRTH WEIGHT BABY 4 0.0005
480 CEREBRAL ATROPHY 2 0.0005
481 ANORECTAL DISORDER 1 0.0005
482 AZOTAEMIA 2 0.0005
483 ARTERIOSPASM CORONARY 2 0.0005
484 MYASTHENIA GRAVIS 4 0.0005
485 HYPOTHERMIA 5 0.0005
486 DIALYSIS 7 0.0005
487 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0005
488 TENSION 3 0.0005
489 NO THERAPEUTIC RESPONSE 6 0.0005
490 CEREBRAL INFARCTION 12 0.0005
491 EXTRAVASATION 2 0.0005
492 ESCHERICHIA INFECTION 4 0.0005
493 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
494 GENERALISED OEDEMA 6 0.0005
495 AKINESIA 1 0.0005
496 MUSCLE INJURY 4 0.0005
497 LIVE BIRTH 4 0.0005
498 MULTIPLE INJURIES 3 0.0005
499 DRUG USE DISORDER 4 0.0005
500 LIP OEDEMA 2 0.0005
501 AORTIC VALVE INCOMPETENCE 2 0.0005
502 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
503 CARDIAC FAILURE CHRONIC 2 0.0005
504 ANAEMIA MACROCYTIC 1 0.0005
505 LUNG NEOPLASM 2 0.0005
506 ANURIA 4 0.0005
507 HEPATIC FAILURE 14 0.0005
508 TOXIC EPIDERMAL NECROLYSIS 7 0.0005
509 ASPIRATION 5 0.0005
510 BIPOLAR I DISORDER 1 0.0005
511 PHYSICAL DISABILITY 2 0.0005
512 ILEUS PARALYTIC 2 0.0004
513 BREAST MASS 3 0.0004
514 PNEUMOTHORAX 7 0.0004
515 DERMATITIS CONTACT 5 0.0004
516 INFARCTION 3 0.0004
517 ECCHYMOSIS 3 0.0004
518 DISEASE COMPLICATION 2 0.0004
519 BLOOD PRESSURE DECREASED 29 0.0004
520 RESPIRATORY ARREST 12 0.0004
521 ISCHAEMIA 2 0.0004
522 SYNOVIAL CYST 2 0.0004
523 LOCALISED OEDEMA 2 0.0004
524 LARGE INTESTINE PERFORATION 3 0.0004
525 HYPOVOLAEMIC SHOCK 2 0.0004
526 FAECAL INCONTINENCE 2 0.0004
527 BLOOD CREATININE INCREASED 27 0.0004
528 BREATH ODOUR 1 0.0004
529 ORAL DISORDER 3 0.0004
530 PSYCHIATRIC SYMPTOM 3 0.0004
531 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
532 STAPHYLOCOCCAL SEPSIS 2 0.0004
533 HYPERVOLAEMIA 2 0.0004
534 ACUTE PSYCHOSIS 1 0.0004
535 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
536 KLEBSIELLA INFECTION 2 0.0004
537 PLEURAL EFFUSION 24 0.0004
538 TROPONIN INCREASED 3 0.0004
539 SUBARACHNOID HAEMORRHAGE 4 0.0004
540 ABDOMINAL INFECTION 1 0.0004
541 WHITE BLOOD CELL COUNT INCREASED 15 0.0004
542 MYDRIASIS 5 0.0004
543 BLOOD CHLORIDE DECREASED 1 0.0004
544 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
545 HIATUS HERNIA 5 0.0004
546 END STAGE RENAL DISEASE 7 0.0004
547 PULMONARY HAEMORRHAGE 3 0.0004
548 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
549 BLOOD POTASSIUM ABNORMAL 1 0.0004
550 DELIRIUM 13 0.0004
551 INTENTIONAL OVERDOSE 24 0.0004
552 ALCOHOL POISONING 1 0.0004
553 ABDOMINAL MASS 1 0.0004
554 ACUTE MYOCARDIAL INFARCTION 11 0.0004
555 BLOOD SODIUM INCREASED 1 0.0004
556 BRADYPNOEA 1 0.0004
557 HYPOKALAEMIA 17 0.0004
558 POLYURIA 3 0.0004
559 JAW DISORDER 2 0.0004
560 PNEUMONIA ASPIRATION 9 0.0004
561 ACUTE KIDNEY INJURY 55 0.0004
562 HYPERGLYCAEMIA 13 0.0004
563 REBOUND EFFECT 4 0.0004
564 DEPRESSION 80 0.0004
565 NEUROLOGICAL SYMPTOM 2 0.0003
566 PSYCHOLOGICAL TRAUMA 3 0.0003
567 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
568 FLUID OVERLOAD 5 0.0003
569 BODY TEMPERATURE INCREASED 7 0.0003
570 SPINAL OSTEOARTHRITIS 3 0.0003
571 ASCITES 10 0.0003
572 LACTIC ACIDOSIS 11 0.0003
573 DECREASED INTEREST 2 0.0003
574 TOXICITY TO VARIOUS AGENTS 57 0.0003
575 HYPERLIPIDAEMIA 4 0.0003
576 PROTHROMBIN TIME PROLONGED 2 0.0003
577 ATYPICAL PNEUMONIA 1 0.0003
578 PAIN 205 0.0003
579 DEVICE RELATED INFECTION 5 0.0003
580 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
581 SCOLIOSIS 2 0.0003
582 ILEUS 4 0.0003
583 INFUSION SITE EXTRAVASATION 2 0.0003
584 PROCTALGIA 2 0.0003
585 HEPATITIS ACUTE 2 0.0003
586 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
587 STAPHYLOCOCCAL INFECTION 10 0.0003
588 PRODUCT FORMULATION ISSUE 2 0.0003
589 PERICARDIAL EFFUSION 7 0.0003
590 HAEMATOCRIT DECREASED 6 0.0003
591 CORONAVIRUS INFECTION 2 0.0003
592 DRUG LEVEL INCREASED 5 0.0003
593 HYPOTONIA 3 0.0003
594 MENINGITIS 2 0.0003
595 PREMATURE BABY 9 0.0003
596 TOXIC SKIN ERUPTION 3 0.0003
597 CONVULSION 17 0.0003
598 BLOOD BILIRUBIN INCREASED 8 0.0003
599 PRODUCT LABEL ISSUE 2 0.0003
600 EPILEPSY 9 0.0003
601 SEIZURE 34 0.0003
602 RESPIRATION ABNORMAL 2 0.0003
603 VENTRICULAR EXTRASYSTOLES 3 0.0003
604 PULMONARY HYPERTENSION 6 0.0003
605 HYPOMAGNESAEMIA 4 0.0003
606 AORTIC STENOSIS 1 0.0003
607 AMENORRHOEA 5 0.0003
608 METASTASIS 2 0.0003
609 CEREBRAL HAEMORRHAGE 10 0.0003
610 DERMATITIS BULLOUS 2 0.0003
611 SKIN LACERATION 3 0.0003
612 CARDIOVASCULAR DISORDER 7 0.0003
613 FAECES SOFT 2 0.0003
614 MAJOR DEPRESSION 2 0.0003
615 ALCOHOL USE 1 0.0003
616 CARDIOMYOPATHY 4 0.0003
617 RASH MACULO-PAPULAR 6 0.0003
618 HYPERTENSIVE CRISIS 3 0.0003
619 HAEMORRHAGE INTRACRANIAL 4 0.0003
620 HYDRONEPHROSIS 2 0.0003
621 CEREBROVASCULAR ACCIDENT 45 0.0003
622 MITRAL VALVE INCOMPETENCE 3 0.0003
623 AUTOIMMUNE THYROIDITIS 1 0.0003
624 HYPOCALCAEMIA 5 0.0003
625 SUICIDE ATTEMPT 16 0.0003
626 AORTIC ANEURYSM 2 0.0003
627 CARDIAC FAILURE CONGESTIVE 21 0.0003
628 DISSOCIATION 2 0.0003
629 ATRIOVENTRICULAR BLOCK 2 0.0003
630 ELECTROLYTE IMBALANCE 3 0.0003
631 HYPOALBUMINAEMIA 2 0.0003
632 BLOOD ALBUMIN DECREASED 2 0.0003
633 ATRIAL FLUTTER 2 0.0003
634 BLOOD DISORDER 2 0.0002
635 CYTOKINE RELEASE SYNDROME 5 0.0002
636 MIOSIS 2 0.0002
637 RESTLESSNESS 9 0.0002
638 ALANINE AMINOTRANSFERASE INCREASED 15 0.0002
639 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
640 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
641 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
642 ACUTE CORONARY SYNDROME 2 0.0002
643 EMBOLISM 2 0.0002
644 BLOOD UREA INCREASED 4 0.0002
645 POISONING 3 0.0002
646 HAEMATEMESIS 6 0.0002
647 CARDIAC FAILURE 19 0.0002
648 HEPATIC CYTOLYSIS 3 0.0002
649 HYPOPHAGIA 6 0.0002
650 FOETAL EXPOSURE DURING PREGNANCY 19 0.0002
651 PSEUDOMONAS INFECTION 2 0.0002
652 LIVER FUNCTION TEST INCREASED 5 0.0002
653 ARRHYTHMIA 11 0.0002
654 MYOPATHY 2 0.0002
655 CARDIAC MURMUR 2 0.0002
656 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
657 BONE CANCER 1 0.0002
658 PRODUCT PRESCRIBING ISSUE 5 0.0002
659 COMPLETED SUICIDE 19 0.0002
660 CARDIOTOXICITY 2 0.0002
661 ISCHAEMIC STROKE 4 0.0002
662 QUALITY OF LIFE DECREASED 3 0.0002
663 HAEMOLYTIC ANAEMIA 2 0.0002
664 HEAD INJURY 7 0.0002
665 BONE DISORDER 4 0.0002
666 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
667 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
668 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
669 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
670 HEPATIC ENCEPHALOPATHY 2 0.0002
671 FLANK PAIN 2 0.0002
672 MATERNAL EXPOSURE DURING PREGNANCY 19 0.0002
673 PAIN IN JAW 6 0.0002
674 HEPATOCELLULAR INJURY 3 0.0002
675 LOSS OF CONSCIOUSNESS 26 0.0002
676 OSTEONECROSIS OF JAW 5 0.0002
677 PULMONARY MASS 3 0.0002
678 ABDOMINAL TENDERNESS 1 0.0002
679 ANEURYSM 1 0.0002
680 AGGRESSION 10 0.0002
681 EMPHYSEMA 2 0.0002
682 ECONOMIC PROBLEM 3 0.0002
683 OSTEOPENIA 3 0.0002
684 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
685 THROMBOCYTOPENIA 22 0.0002
686 MOTOR DYSFUNCTION 2 0.0002
687 AMMONIA INCREASED 1 0.0002
688 MYOCARDIAL INFARCTION 34 0.0002
689 CACHEXIA 1 0.0002
690 TEMPERATURE INTOLERANCE 2 0.0002
691 HYPERBILIRUBINAEMIA 2 0.0002
692 NERVOUSNESS 10 0.0002
693 HYPERTENSION 40 0.0002
694 ULCER 3 0.0002
695 ABSCESS 3 0.0002
696 ANAL ABSCESS 1 0.0002
697 DECREASED ACTIVITY 2 0.0002
698 OEDEMA 10 0.0002
699 CHRONIC KIDNEY DISEASE 14 0.0002
700 MENTAL DISORDER 8 0.0002
701 TOOTH FRACTURE 2 0.0002
702 ANGIOEDEMA 8 0.0002
703 DENTAL CARIES 2 0.0002
704 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
705 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
706 FEELING COLD 5 0.0002
707 PANCYTOPENIA 10 0.0002
708 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
709 HEMIPARESIS 3 0.0002
710 EXPOSURE DURING PREGNANCY 11 0.0002
711 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
712 RED BLOOD CELL COUNT DECREASED 5 0.0002
713 BLOOD URIC ACID INCREASED 1 0.0002
714 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
715 DYSKINESIA 7 0.0002
716 NEUROTOXICITY 3 0.0002
717 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
718 DRUG ERUPTION 3 0.0002
719 CHOLECYSTITIS 2 0.0002
720 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
721 ANAEMIA 32 0.0002
722 ACCIDENT 2 0.0002
723 RESPIRATORY DISORDER 5 0.0002
724 DRUG EFFECT DECREASED 9 0.0002
725 BLOOD PRESSURE FLUCTUATION 4 0.0002
726 OSTEOMYELITIS 3 0.0002
727 APHASIA 5 0.0002
728 BLOOD GLUCOSE ABNORMAL 3 0.0002
729 MEDICATION ERROR 9 0.0002
730 BACTERIAL INFECTION 3 0.0002
731 NERVOUS SYSTEM DISORDER 5 0.0002
732 HYPONATRAEMIA 9 0.0002
733 BLEPHAROSPASM 1 0.0002
734 HAEMATOMA 4 0.0002
735 OVERDOSE 33 0.0002
736 ASPERGILLUS INFECTION 1 0.0002
737 ORAL CANDIDIASIS 2 0.0002
738 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
739 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
740 DISORIENTATION 6 0.0002
741 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
742 ADVERSE REACTION 2 0.0002
743 PRODUCT ADMINISTRATION ERROR 3 0.0001
744 BRONCHIECTASIS 1 0.0001
745 PNEUMONITIS 4 0.0001
746 GINGIVAL BLEEDING 2 0.0001
747 RIB FRACTURE 3 0.0001
748 DEATH 125 0.0001
749 PERITONITIS 3 0.0001
750 HYPOGLYCAEMIA 7 0.0001
751 MASS 2 0.0001
752 HALLUCINATION, VISUAL 3 0.0001
753 LYMPHOPENIA 2 0.0001
754 MUSCULAR WEAKNESS 16 0.0001
755 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
756 SUBDURAL HAEMATOMA 2 0.0001
757 DEEP VEIN THROMBOSIS 9 0.0001
758 PRODUCT DISPENSING ERROR 3 0.0001
759 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
760 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
761 PRODUCT USE IN UNAPPROVED INDICATION 34 0.0001
762 APATHY 2 0.0001
763 DRUG WITHDRAWAL SYNDROME NEONATAL 2 0.0001
764 WHEEZING 8 0.0001
765 HEPATOTOXICITY 3 0.0001
766 ORAL PAIN 3 0.0001
767 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
768 HAEMORRHAGE 14 0.0001
769 CHROMATURIA 3 0.0001
770 DRUG INEFFECTIVE 175 0.0001
771 CORONARY ARTERY DISEASE 4 0.0001
772 HEPATIC ENZYME INCREASED 9 0.0001
773 PHARYNGEAL OEDEMA 2 0.0001
774 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
775 CHILLS 15 0.0001
776 PYREXIA 44 0.0001
777 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
778 PRODUCT QUALITY ISSUE 17 0.0001
779 CONFUSIONAL STATE 20 0.0001
780 ASPHYXIA 1 0.0001
781 ABNORMAL FAECES 1 0.0001
782 PLATELET COUNT DECREASED 13 0.0001
783 IMPAIRED HEALING 4 0.0001
784 CYTOMEGALOVIRUS INFECTION 2 0.0001
785 URINARY RETENTION 4 0.0001
786 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
787 OSTEOARTHRITIS 5 0.0001
788 CARDIAC DISORDER 11 0.0001
789 PNEUMONIA 38 0.0001
790 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
791 DIPLOPIA 3 0.0001
792 ORTHOSTATIC HYPOTENSION 2 0.0001
793 MUCOSAL INFLAMMATION 3 0.0001
794 GASTRITIS 3 0.0001
795 LYMPHOCYTE COUNT DECREASED 2 0.0001
796 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
797 THROMBOSIS 9 0.0001
798 PALLOR 3 0.0001
799 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
800 HYPERHIDROSIS 14 0.0001
801 TREATMENT FAILURE 9 0.0001
802 ADVERSE EVENT 10 0.0001
803 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
804 AMNESIA 7 0.0001
805 APPENDICITIS 1 0.0001
806 ARTERIOSCLEROSIS 1 0.0001
807 BLOOD SODIUM DECREASED 2 0.0001
808 ABDOMINAL DISTENSION 11 0.0001
809 GASTRIC ULCER 2 0.0001
810 PROTEINURIA 2 0.0001
811 SLEEP APNOEA SYNDROME 2 0.0001
812 ANGINA PECTORIS 3 0.0001
813 SOMNOLENCE 21 0.0001
814 AFFECT LABILITY 1 0.0001
815 LUNG DISORDER 5 0.0001
816 CONDITION AGGRAVATED 31 0.0001
817 UPPER LIMB FRACTURE 2 0.0001
818 IRRITABILITY 6 0.0001
819 BRAIN INJURY 1 0.0001
820 BONE MARROW FAILURE 2 0.0001
821 THERAPY CESSATION 5 0.0001
822 EMOTIONAL DISORDER 3 0.0001
823 INFLAMMATION 5 0.0001
824 TREMOR 16 0.0001
825 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
826 ROAD TRAFFIC ACCIDENT 4 0.0001
827 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
828 MOUTH ULCERATION 2 0.0001
829 HYPOTHYROIDISM 3 0.0001
830 EATING DISORDER 2 0.0001
831 RASH PRURITIC 5 0.0001
832 BIPOLAR DISORDER 1 0.0001
833 INTENTIONAL PRODUCT MISUSE 8 0.0001
834 FEBRILE NEUTROPENIA 6 0.0001
835 EXPIRED PRODUCT ADMINISTERED 3 0.0001
836 LIVER DISORDER 4 0.0001
837 STEVENS-JOHNSON SYNDROME 2 0.0001
838 TOOTH DISORDER 2 0.0001
839 BLOOD CALCIUM DECREASED 1 0.0001
840 ERYTHEMA 18 0.0001
841 DYSPHAGIA 8 0.0001
842 OFF LABEL USE 73 0.0001
843 DYSPNOEA 47 0.0001
844 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
845 MENTAL IMPAIRMENT 2 0.0001
846 ACCIDENTAL OVERDOSE 3 0.0001
847 HEART RATE INCREASED 8 0.0001
848 INTESTINAL OBSTRUCTION 3 0.0001
849 PRODUCT COMPLAINT 2 0.0001
850 ERECTILE DYSFUNCTION 2 0.0001
851 SKIN ULCER 2 0.0001
852 PLASMA CELL MYELOMA 3 0.0001
853 BEDRIDDEN 1 0.0001
854 DISEASE PROGRESSION 9 0.0001
855 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
856 COVID-19 13 0.0001
857 MOOD ALTERED 2 0.0001
858 ACUTE HEPATIC FAILURE 1 0.0001
859 TREATMENT NONCOMPLIANCE 4 0.0001
860 HAEMOPTYSIS 2 0.0001
861 WOUND 2 0.0001
862 LETHARGY 4 0.0001
863 ABDOMINAL PAIN 16 0.0001
864 LIVER FUNCTION TEST ABNORMAL 2 0.0001
865 NEEDLE ISSUE 2 0.0001
866 PRODUCT STORAGE ERROR 6 0.0001
867 DYSSTASIA 2 0.0001
868 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
869 SURGERY 4 0.0001
870 HAEMOGLOBIN DECREASED 7 0.0001
871 URINARY INCONTINENCE 2 0.0001
872 THERAPY NON-RESPONDER 3 0.0001
873 NEUTROPENIA 9 0.0001
874 DISCOMFORT 4 0.0001
875 CHEST PAIN 12 0.0001
876 HYPERSENSITIVITY 12 0.0001
877 COGNITIVE DISORDER 3 0.0001
878 SWOLLEN TONGUE 2 0.0001
879 BONE DENSITY DECREASED 2 0.0001
880 DRUG-INDUCED LIVER INJURY 2 0.0001
881 PULMONARY EMBOLISM 6 0.0001
882 MOOD SWINGS 2 0.0001
883 NIGHT SWEATS 2 0.0001
884 VOMITING 29 0.0001
885 BLOOD POTASSIUM INCREASED 1 0.0001
886 COUGH 17 0.0001
887 SYNCOPE 6 0.0001
888 CONSTIPATION 13 0.0001
889 CELLULITIS 3 0.0001
890 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
891 GASTRIC DISORDER 2 0.0001
892 OEDEMA PERIPHERAL 7 0.0001
893 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
894 PANCREATITIS 3 0.0001
895 LYMPHADENOPATHY 2 0.0001
896 DISTURBANCE IN ATTENTION 3 0.0001
897 C-REACTIVE PROTEIN INCREASED 2 0.0001
898 SUICIDAL IDEATION 5 0.0001
899 AGRANULOCYTOSIS 1 0.0001
900 URTICARIA 9 0.0001
901 DYSPNOEA EXERTIONAL 2 0.0001
902 HALLUCINATION 4 0.0001
903 BLOOD URINE PRESENT 1 0.0001
904 NEUROPATHY PERIPHERAL 5 0.0001
905 DIABETES MELLITUS 4 0.0001
906 HERPES ZOSTER 3 0.0001
907 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
908 OSTEOPOROSIS 2 0.0000
909 INFECTION 7 0.0000
910 POLLAKIURIA 2 0.0000
911 WITHDRAWAL SYNDROME 2 0.0000
912 URINARY TRACT INFECTION 8 0.0000
913 HYPOAESTHESIA 7 0.0000
914 BLOOD PRESSURE INCREASED 7 0.0000
915 NO ADVERSE EVENT 8 0.0000
916 DIZZINESS 22 0.0000
917 SKIN DISCOLOURATION 2 0.0000
918 WEIGHT DECREASED 12 0.0000
919 RENAL DISORDER 2 0.0000
920 ASTHENIA 16 0.0000
921 FALL 14 0.0000
922 PRODUCTIVE COUGH 2 0.0000
923 RASH ERYTHEMATOUS 2 0.0000
924 BLOOD GLUCOSE DECREASED 2 0.0000
925 CONTUSION 4 0.0000
926 INTERSTITIAL LUNG DISEASE 2 0.0000
927 MYALGIA 7 0.0000
928 ABASIA 1 0.0000
929 EPISTAXIS 3 0.0000
930 LEUKOPENIA 2 0.0000
931 NAUSEA 31 0.0000
932 ECZEMA 2 0.0000
933 MUSCULOSKELETAL PAIN 2 0.0000
934 DEHYDRATION 5 0.0000
935 BREAST CANCER FEMALE 1 0.0000
936 RASH 16 0.0000
937 MEMORY IMPAIRMENT 5 0.0000
938 HAEMATOCHEZIA 2 0.0000
939 NECK PAIN 2 0.0000
940 EYE PAIN 2 0.0000
941 DYSPHONIA 2 0.0000
942 INSOMNIA 9 0.0000
943 BLOOD POTASSIUM DECREASED 1 0.0000
944 STOMATITIS 2 0.0000
945 ILL-DEFINED DISORDER 2 0.0000
946 SWELLING 3 0.0000
947 GAIT DISTURBANCE 6 0.0000
948 DRUG INTOLERANCE 3 0.0000
949 DIARRHOEA 20 0.0000
950 SWELLING FACE 2 0.0000
951 DYSPEPSIA 3 0.0000
952 INFUSION RELATED REACTION 2 0.0000
953 BACK PAIN 7 0.0000
954 FATIGUE 23 0.0000
955 ABDOMINAL PAIN UPPER 6 0.0000
956 BURNING SENSATION 2 0.0000
957 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
958 UNDERDOSE 2 0.0000
959 BRONCHITIS 2 0.0000
960 PALPITATIONS 3 0.0000
961 ARTHRITIS 2 0.0000
962 ABNORMAL BEHAVIOUR 1 0.0000
963 DRY MOUTH 2 0.0000
964 BLINDNESS 1 0.0000
965 MUSCULOSKELETAL STIFFNESS 2 0.0000
966 DRUG WITHDRAWAL SYNDROME 2 0.0000
967 ADVERSE DRUG REACTION 2 0.0000
968 DECREASED APPETITE 5 0.0000
969 PRODUCT USE ISSUE 4 0.0000
970 BLOOD GLUCOSE INCREASED 4 0.0000
971 PAIN IN EXTREMITY 6 0.0000
972 FLUSHING 2 0.0000
973 CHEST DISCOMFORT 2 0.0000
974 SINUSITIS 2 0.0000
975 PARAESTHESIA 3 0.0000
976 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
977 PRURITUS 7 0.0000
978 BLISTER 1 0.0000
979 ASTHMA 2 0.0000
980 BONE PAIN 1 0.0000
981 MUSCLE SPASMS 3 0.0000
982 NASOPHARYNGITIS 3 0.0000
983 VISUAL IMPAIRMENT 2 0.0000
984 MALAISE 7 0.0000
985 ALOPECIA 3 0.0000
986 HEADACHE 9 0.0000
987 INCORRECT DOSE ADMINISTERED 3 0.0000
988 INJECTION SITE PAIN 4 0.0000
989 DRUG DEPENDENCE 2 0.0000
990 ABDOMINAL DISCOMFORT 2 0.0000
991 BALANCE DISORDER 1 0.0000
992 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
993 FEELING ABNORMAL 2 0.0000
994 ARTHRALGIA 3 0.0000